|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (SCL and AW), and the Department of Surgery and Centre for Clinical Research, Central Hospital, Västerås, Sweden (LB).
2 Supported by research grants from the Swedish Cancer Foundation and the Swedish Research Council for Infrastructure. 3 Address correspondence to SC Larsson, Division of Nutritional Epidemiology, National Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE-17177 Stockholm, Sweden. E-mail: susanna.larsson{at}ki.se.
Background: Studies in animals and in vitro suggest that conjugated linoleic acids (CLAs), a group of fatty acids found mainly in dairy products and in the meat of ruminants, have protective effects against mammary carcinogenesis. However, findings from epidemiologic studies on CLA intake in relation to breast cancer risk are sparse and inconsistent.
Objective: The objective was to examine prospectively the association between CLA intake and the incidence of invasive breast cancer in the Swedish Mammography Cohort.
Design: In 1987–1990, 61,433 cancer-free women completed a food-frequency questionnaire from which we estimated each woman's CLA intake. Cox proportional hazards models were used to estimate relative risks, adjusted for breast cancer risk factors.
Results: During a mean follow-up of 17.4 y, 2952 incident cases of breast cancer were ascertained. In multivariate analyses, no significant association was observed between dietary CLA intake and risk of breast cancer, overall or by estrogen receptor (ER) and progesterone receptor (PR) status. The multivariate relative risks (95% CI) for the highest quintile of CLA intake (
155.7 mg/d) compared with the lowest quintile (<78.1 mg/d) were 1.04 (0.92, 1.17) for overall breast cancer, 1.09 (0.90, 1.31) for ER+/PR+ tumors, 1.09 (0.78, 1.53) for ER+/PR– tumors, and 0.84 (0.57, 1.24) for ER–/PR– tumors.
Conclusion: The results provide no evidence of a protective effect of CLA against breast cancer development in women.
Related articles in AJCN:
This article has been cited by other articles:
![]() |
E. Linos and W. Willett Meat, dairy, and breast cancer: do we have an answer? Am. J. Clinical Nutrition, September 1, 2009; 90(3): 455 - 456. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |